ArticleCureus2022
A Cross-Sectional Study of the Association of ABO Blood Group and Rh Type With Severity of COVID-19 Infection in a Tertiary Care Center of South India.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Association Between Rhesus and ABO Blood Group Types and Their Impact on Clinical Outcomes in Critically Ill Patients with COVID-19: A Multi-Center Investigation.Infection and drug resistance · 2024Article
- Effects of ABO blood groups and RH-factor on COVID-19 transmission, course and outcome: A review.Frontiers in medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The novel coronavirus disease 2019 (COVID-19) was declared a pandemic that had affected 224 countries, causing >2.1 million deaths worldwide. The association of the different ABO blood groups with the risk and severity of COVID-19 infections has been speculated in many studies. This study aims to determine the incidence of COVID-19 infections among various blood groups and the association of ABO blood groups and Rh type with the severity of COVID-19 infection as well as with other outcome predictors of COVID-19 infection including neutrophil-to-lymphocyte ratio, D-dimer, ferritin, lactate dehydrogenase, and C-reactive protein. Methodology This was a retrospective study conducted among 150 serologically positive patients >18 years of age who underwent treatment in a district government hospital over two months. Patients were categorized into severity groups, and laboratory data were divided into those corresponding to severe disease and otherwise, in accordance with national guidelines. Appropriate statistical analysis was performed. Results The frequency of blood groups A, B, AB, and O was 30.7%, 29.4%, 13.7%, and 39%, respectively. There was a statistically significant number of patients belonging to non-O blood groups who developed a severe COVID-19 infection (group C) (p = 0.005). There was an increased risk of multiorgan failure (p = 0.035), non-invasive ventilation (p = 0.005), intubation, and mortality among non-O blood groups, and was the maximum for A blood group even after adjusting for age and pre-existing comorbidities. Increased D-dimer levels were noted in non-O blood groups (p = 0.037). No statistically significant association was found between Rh typing and the severity of COVID-19 infection. Conclusions Our findings provide evidence that individuals with non-O blood groups are susceptible to developing more severe COVID-19 infections and should take active preventive measures. Moreover, they should be cautiously monitored and treated once infected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.